“The GI Genius intelligent endoscopy module has the potential to make a world-changing impact and we’re thrilled to recognize Medtronic for this achievement”
LOS ANGELES (PRWEB)
June 21, 2023
AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Medtronic plc, the leading global healthcare technology company, has been selected as winner of the “Best Deep Learning Platform” award in the sixth annual AI Breakthrough Awards program, recognizing the breakthrough innovation of Medtronic’s GI Genius™ system.
The GI Genius™ system, developed by Cosmo Intelligent Medical Devices, is an intelligent endoscopy module that uses AI to assist physicians in detecting polyps, in real-time, during a colonoscopy procedure. GI Genius is the first FDA authorized computer-aided detection (CADe) system using AI to help endoscopists identify colorectal polyps, regardless of shape, size, or morphology.
GI Genius leverages deep learning to support a clinician’s assessment of diagnostic images as it supplements colonoscopies with real-time image analysis of any colonoscopy video and scans every visual frame of the procedure to alert physicians to the presence of lesions – including small, flat polyps that can go undetected by even the most trained human eye.
Additionally, the software built into GI Genius has a robust dataset of more than 13 million polyp images and, as the datasets grow, the intelligent endoscopy module continues to learn, increasing better performance and accuracy. A recent announcement showcased the vision of GI Genius’ capability of hosting multiple AI algorithms.
“It’s an honor to have GI Genius selected for this award,” said Giovanni Di Napoli, president of the Medtronic Gastrointestinal business, which is part of the Medical Surgical Portfolio at Medtronic. “Our aim is to improve colonoscopies and increase early detection of potentially precancerous colorectal polyps. GI Genius doesn’t get tired or distracted, and it augments human intelligence with the potential to transform the way healthcare is delivered. Our expanding AI capabilities at Medtronic create opportunities to deliver against unmet needs, including across the Gastrointestinal (GI) practice.”
The mission of the AI Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of AI and machine learning related categories, including Generative AI, Computer Vision, AIOps, Deep Learning, Robotics, Natural Language Processing, industry specific AI applications and many more. This year’s program attracted more than 3,200 nominations from over 20 different countries throughout the world.
“The GI Genius intelligent endoscopy module has the potential to make a world-changing impact and we’re thrilled to recognize Medtronic for this achievement. Colorectal cancer is the second-leading cause of cancer related deaths in the U.S., yet 90% of people can beat it if diagnosed early. Screening is one of the most effective ways of doing that. However, colonoscopy is difficult, and polyps may be difficult to find,” said James Johnson, managing director, AI Breakthrough. “Congratulations to Medtronic. This world-changing, AI-driven innovation couldn’t come at a more pressing time as gastroenterologists manage an overwhelming backlog of colonoscopies.”
In the past two years since FDA authorization, Medtronic’s facilitation of the Health Equity Assistance Program provided 130 GI Genius units to underserved communities that otherwise would not receive the technology.
####
About AI Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the AI Breakthrough Awards program is devoted to honoring excellence in Artificial Intelligence technologies, services, companies and products. The AI Breakthrough Awards provide public recognition for the achievements of AI companies and products in categories including AI Platforms, Robotics, Business Intelligence, AI Hardware, NLP, Computer Vision and more. For more information visit AIBreakthroughAwards.com.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit Medtronic.com and follow @Medtronic on Twitter and LinkedIn.
Share article on social media or email: